Displaying 76–100 of 631 results for Pharmaceutical Manufacturing staff

Sort By Relevance Sort By Date
1... 2 3 4 5 6 ...26

Regulatory Resolutions

(Article)

CDER Director Janet Woodcock takes a look back and a look forward

Germany’s Solid Dose PowerHouse: Rottendorf

(Article)

Sponsors energize their solid dose formulations here

Unlocking the Value of Supply Chain Collaboration

(Article)

An increasing focus on contract manufacturing can be expected to drive the need for more advanced cooperation models

EU Certifies Vetter’s Supply Chain is Better

(News)

Authorized Economic Operator FullRecognizes Company’s Operational Excellence

Quality Management in the Digital Age

(Article)

An operational approach such as Pharma 4.0 that connects all resources via the Cloud can be a really good thing

Packaging Line Scheduling Optimization

(Article)

Scheduling software brings artificial intelligence to address packaging processing complexity at Pfizer

The Joy of Capital Spending

(Article)

India’s Top 20 Pharma companies are upgrading facilities to proactively enjoy Pharma market opportunities

Telstar Completes Two cGMP Plants for Square Pharma

(News)

Telstar recently completed two new pharmaceutical manufacturing plants for Bangladesh-based Square Pharmaceuticals, a CMO with plans to process liquid and solid dose forms in the new facilities.

Survey of India Pharma Attributes Compliance Woes to Shortage of Skilled ...

(News)

A recent Deloitte India survey of risk and compliance professionals at India-based pharmaceutical companies found that a shortage of skilled manpower is cited as the leading reason that India drug companies are unable to keep pace with rapidly changing regulatory environments.

Environmental Monitoring in Pharma Labs

(Article)

Data Logger FAQs reveal application insights

Cultivating Better Contract Services

(Article)

WellSpring Pharmaceutical Services wants to sew the seeds of its customer success

Valeant CFO to Resign, New EVP/Group Chairman Joins Team

(News)

Following its recent $11.1 billion Salix buy and a boosted revenue forcast, Valeant has announced two key executive staff changes.

CSM to Build Second cGMP Facility in Malvern, PA

(News)

Operational expansion will support the company’s overall vision and continued growth

In it for the Long Haul

(Article)

PhM's 2015 Reader Survey finds Pharma's professionals satisfied with their careers and leery of corporate "change" related to acquisitions, restructuring and cost control

Bringing Mobility into IT Strategy

(Article)

Flexibility of operations and performance agility add new dimension to Pharma IT strategy

PerkinElmer Equips J&J Innovation JLABS’ Incubator

(News)

PerkinElmer will provide on-site staff and training as well as scientific application support, a new offering to JLABS residents

Mature Quality Systems: What Pharma Can Learn from Other Industries

(Article)

Pharma can take inspiration from industries with mature quality systems and advanced quality capabilities

Our Website Just Got Sexier

(Article)

Our design team, programmers and editorial staff have worked behind the scenes for the last six months to re-imagine PharmaManufacturing.com.

DOE Reduces Bioequivalent Generic Development Time to 4 Months

(Article)

VerGo employs Stat-Ease Inc., software to design optimal three-factor experiment

Management Holds the Key to Continued Process Verification

(Article)

CPV must be implemented as a system, complete with a strategy and plan for implementation and sustainability throughout the lifecycle of the process/product

FDA’s Quality Beat Goes On

(News)

CDER’s Office of Pharmaceutical Quality Debuts as part of its ongoing Quality Initiative

Management’s Role in Sustaining Continued Process Verification

(Article)

A Continued Process Verification approach based only on statistical tools addresses only the operational level of the system; management needs to be involved

No Surprise, Demand for Biopharma Production Capacity to Rise

(News)

The biopharmaceutical and vaccine production market is estimated to reach $41 billion in 2014

Risky Business: High Potency Products

(Article)

Manufacturing HP active pharmaceutical ingredient drugs is a challenge best met with a thorough assessment of risk and a robust containment strategy

Sort By Relevance Sort By Date
1... 2 3 4 5 6 ...26